The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Intravitreal triamcinolone acetonide for exudative age related macular degeneration
Open accessAbstract
AIM: To evaluate the effect of intravitreal triamcinolone acetonide on the visual acuity of patients with exudative age related macular degeneration, to assess the duration of a possible effect, and to evaluate clinical side effects of the treatment. METHODS: The study included 67 patients (71 eyes) who presented with exudative age related macular degeneration of predominantly or total occult type (n = 68) or classic type (n = 3), and who received once, or repeatedly, an intravitreal injection of 25 mg of crystalline triamcinolone acetonide. Mean follow up time was 7.46 (SD 3.54) months (range 3.1-19.57 months). RESULTS: Visual acuity increased significantly (p <0.001) from 0.16 (0.11) to a mean maximum of 0.23 (0.17). Postoperative visual acuity was highest 1-3 months after the injection. 47 (66.2%) eyes gained in maximal visual acuity and 11 (15.5%) eyes lost in visual acuity. Intraocular pressure increased significantly (p <0.001) from 15.1 (3.1) mm Hg at baseline to a maximal value of 23.0 (8.25) mm Hg. At the end of follow up, intraocular pressure again decreased significantly (p<0.001) to 16.8 (4.9) mm Hg. No cases of postoperative infectious endophthalmitis, rhegmatogenous retinal detachment, or proliferative vitreoretinopathy occurred. Owing to a decrease in visual acuity after an initial increase, six patients received a second intravitreal triamcinolone acetonide injection after which visual acuity increased again in three eyes. CONCLUSIONS: Intravitreal injection of 25 mg of crystalline triamcinolone acetonide merits further study for the treatment of exudative age related macular degeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1999) · Archives of Ophthalmology · doi:10.1001/archopht.117.10.1329 · Cited by 2,192
Prevalence of age-related maculopathy in Australia
Mitchell, P., Smith, W., Attebo, K., & Wang, J. J. (1995) · Ophthalmology · doi:10.1016/s0161-6420(95)30846-9 · Cited by 1,062
Intravitreal triamcinolone for refractory diabetic macular edema
Martidis, A., Duker, J. S., Greenberg, P. B., Rogers, A. H., Puliafito, C. A., Reichel, E., & Baumal, C. (2002) · Ophthalmology · doi:10.1016/s0161-6420(02)00975-2 · Cited by 1,032
The Prevalence of Age-related Maculopathy in the Rotterdam Study
Vingerling, J. R., Dielemans, I., Hofman, A., Grobbee, D. E., Hijmering, M., Kramer, C. F. L., & de Jong, P. T. V. M. (1995) · Ophthalmology · doi:10.1016/s0161-6420(95)31034-2 · Cited by 815
Age-related macular degeneration
Bressler, N. M., Bressler, S. B., & Fine, S. L. (1988) · Survey of Ophthalmology · doi:10.1016/0039-6257(88)90052-5 · Cited by 681
Ophthalmoscopic Evaluation of the Optic Nerve Head
Jonas, J. B., Budde, W. M., & Panda-Jonas, S. (1999) · Survey of Ophthalmology · doi:10.1016/s0039-6257(98)00049-6 · Cited by 607
Self-citationBressler, N. M. (2001) · Cited by 599
Intravitreal Injection of Triamcinolone for Diffuse Diabetic Macular Edema
Jonas, J. B. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.1.57 · Cited by 563
Self-citationIntravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study
Antcliff, R. J., Spalton, D. J., Stanford, M. R., Graham, E. M., ffytche, T. J., & Marshall, J. (2001) · Ophthalmology · doi:10.1016/s0161-6420(00)00658-8 · Cited by 487
Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema
Jonas, J. B., & Söfker, A. (2001) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(01)01010-8 · Cited by 481
Self-citation
Cited by
Intravitreal triamcinolone for refractory diabetic macular edema
Martidis, A., Duker, J. S., Greenberg, P. B., Rogers, A. H., Puliafito, C. A., Reichel, E., & Baumal, C. (2002) · Ophthalmology · doi:10.1016/s0161-6420(02)00975-2 · Cited by 1,032
The Natural History and Prognosis of Neovascular Age-Related Macular Degeneration
Wong, T., Chakravarthy, U., Klein, R., Mitchell, P., Zlateva, G., Buggage, R., Fahrbach, K., Probst, C., & Sledge, I. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2007.03.008 · Cited by 601
RISKS OF INTRAVITREOUS INJECTION: A COMPREHENSIVE REVIEW
JAGER, R. D., AIELLO, L. P., PATEL, S. C., & CUNNINGHAM, E. T. (2004) · Retina · doi:10.1097/00006982-200410000-00002 · Cited by 572
Beer, P. M., Bakri, S. J., Singh, R. J., Liu, W., Peters, G. B., & Miller, M. (2003) · Ophthalmology · doi:10.1016/s0161-6420(02)01969-3 · Cited by 570
Intravitreal Injection of Triamcinolone for Diffuse Diabetic Macular Edema
Jonas, J. B. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.1.57 · Cited by 563
Self-citationImmunological and Aetiological Aspects of Macular Degeneration
Penfold, P. L., Madigan, M. C., Gillies, M. C., & Provis, J. M. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(00)00025-2 · Cited by 460
Intraocular pressure after intravitreal injection of triamcinolone acetonide
Jonas, J. B. (2003) · British Journal of Ophthalmology · doi:10.1136/bjo.87.1.24 · Cited by 422
Self-citationEspinosa-Heidmann, D. G., Suner, I. J., Hernandez, E. P., Monroy, D., Csaky, K. G., & Cousins, S. W. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.03-0038 · Cited by 401
Acute endophthalmitis following intravitreal triamcinolone acetonide injection
Moshfeghi, D. M., Kaiser, P. K., Scott, I. U., Sears, J. E., Benz, M., Sinesterra, J. P., Kaiser, R. S., Bakri, S. J., Maturi, R. K., Belmont, J., et al. (2003) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(03)00483-5 · Cited by 397
Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion
Greenberg, P. B. (2002) · British Journal of Ophthalmology · doi:10.1136/bjo.86.2.247 · Cited by 370
Seddon, J. M. (2005) · Archives of Ophthalmology · doi:10.1001/archopht.123.6.774 · Cited by 354
Intraocular Pressure Elevation After Intravitreal Triamcinolone Acetonide Injection
JONAS, J., DEGENRING, R., KREISSIG, I., AKKOYUN, I., & KAMPPETER, B. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2004.10.042 · Cited by 323
Self-citationGillies, M. C. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.5.667 · Cited by 298
Intravitreal triamcinolone acetonide and intraocular pressure
Smithen, L. M., Ober, M. D., Maranan, L., & Spaide, R. F. (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2004.06.067 · Cited by 296
Recent Advances in Ophthalmic Drug Delivery
Kompella, U. B., Kadam, R. S., & Lee, V. H. (2010) · Therapeutic Delivery · doi:10.4155/tde.10.40 · Cited by 285
INTRAVITREAL INJECTION OF THERAPEUTIC AGENTS
PEYMAN, G. A., LAD, E. M., & MOSHFEGHI, D. M. (2009) · Retina · doi:10.1097/iae.0b013e3181a94f01 · Cited by 255
NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Natural History and Treatment Outcomes
Pauleikhoff, D. (2005) · Retina · doi:10.1097/00006982-200512000-00016 · Cited by 108
Association of HLA Class I and Class II Polymorphisms with Age-Related Macular Degeneration
Goverdhan, S. V., Howell, M. W., Mullins, R. F., Osmond, C., Hodgkins, P. R., Self, J., Avery, K., & Lotery, A. J. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-0928 · Cited by 78
Metadata
- Authors
- Jonas, J. B.
- Venue
- British Journal of Ophthalmology
- Publisher
- BMJ
- Published
- 2003-04-01
- Volume
- 87
- Issue
- 4
- Pages
- 462-468
- ISSN
- 0007-1161 (ISSN-L)
- OpenAlex
- W2170353976
- Cited by
- 492
- References
- 44
- FWCI
- 83.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.